Skip to main content
Irene Kang, MD, Oncology, Irvine, CA

IreneMoraeKangMD

Oncology • Irvine, CA

Breast Cancer, Hematologic Oncology

Assistant Professor of Medical Oncology and Therapeutics Research

Join to view full profile

Dr. Kang is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Kang's full profile

Already have an account?

  • Office

    1000 FivePoint
    Irvine, CA 92618
    Phone+1 888-333-4673
    Fax+1 949-671-4330

Summary

  • Dr. Irene Kang is an oncologist in Irvine, CA and medical director of Women’s Health Oncology at the City of Hope, Orange County. She received her medical degree from University of California (San Francisco) School of Medicine and has been in practice 7 years. She also speaks Korean. She specializes in breast cancer. She has more than 20 publications and over 350 citings.

Education & Training

  • University of Southern California/LAC+USC Medical Center
    University of Southern California/LAC+USC Medical CenterFellowship, Medical Oncology, 2014 - 2017
  • Santa Clara Valley Medical Center
    Santa Clara Valley Medical CenterResidency, Internal Medicine, 2011 - 2014
  • University of California San Francisco School of Medicine
    University of California San Francisco School of MedicineClass of 2011

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2013 - 2026
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • Phase II trial of metronomic capecitabine and cyclophosphamide with lapatinib and trastuzumab in patients with HER2-positive metastatic breast cancer. 
    2019 ASCO Annual Meeting - 6/1/2019

Press Mentions

  • Commentary: Don’t Be Puzzled by Evolving Mammogram Guidelines
    Commentary: Don’t Be Puzzled by Evolving Mammogram GuidelinesMay 25th, 2023
  • Recommended Age for Starting Breast Cancer Screenings Lowered from 50 to 40
    Recommended Age for Starting Breast Cancer Screenings Lowered from 50 to 40May 12th, 2023
  • Why Women Should Start Getting Regular Mammograms at Age 40
    Why Women Should Start Getting Regular Mammograms at Age 40May 10th, 2023
  • Join now to see all

Other Languages

  • Korean

Dr. Irene Kang, Dr. Irene Kang, MD, Dr. I Kang, Dr. Irene Morae Kang